Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide plus whole-brain radiotherapy for unresectable brain metastases
2009-014481-26Phase 2Active
- Sponsor
- San Salvatore Hospital of L'Aquila
- Start
- Oct 2009
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temozolomide in brain metastases, sponsored by San Salvatore Hospital of L'Aquila. Primary endpoint: Radiologic response. Started Oct 2009; status: active.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on 2009-014481-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014481-26.